Log in

The 8-hour MOUD Training

The Providers Clinical Support System-Medications for Opioid Use Disorders (PCSS-MOUD) is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and created in response to the opioid overdose epidemic. PCSS-MOUD’s goal is to provide evidence-based practices to improve healthcare and outcomes in the prevention of those at risk and treatment for individuals with an opioid use disorder (OUD).

PCSS-MOUD is led by the American Academy of Addiction Psychiatry (AAAP) in collaboration with AOAAM and an extensive coalition of national professional and healthcare organizations. PCSS-MOUD provides multidisciplinary training, guidance, mentorship, and implementation support at no cost to healthcare and behavioral health professionals to identify and treat their patients using U.S. Food and Drug Administration-approved (FDA) medications for opioid use disorder (MOUD). The overarching goal of PCSS-MOUD is to increase healthcare professionals’ knowledge, skills, and confidence in providing evidence-based practices in the prevention, treatment, recovery, and harm reduction of OUD.

Program Overview
1st Half of the Course

 A 4.25-hour live webcast session, consisting of four modules, case studies and a q&a session. The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. 1A AOA CME and AAFP CME is offered and sponsored by the AOAAM for this session.

2nd Half of the Course
An additional 4.0 hours of either on-your-own computer-based study or  four individual, 1-hour OnDemand modules, that when combined with the 4.25-hour session will fulfill the 8-hour DEA training requirement. Directions and access will be provided via email once it has been verified that the first half of the course has been completed in its entirety. The 4.0-hour self-study is sponsored by AAAP, and offers CME credits that are jointly accredited by ACCME, ACPE, and ANCC.
The individual OnDemand modules are sponsored by the AOAAM and offer AOA 1A and AMA PRA credit.

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent and obtain a waiver to your DEA license to prescribe schedule III-V medications, approved by the FDA for the treatment of opioid use disorder (OUD).

The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.

Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form, affirming that they have completed the new training requirement.

This training will count towards the DEA’s new 8-hour training

requirement when applying for or renewing your DEA license.


Program Goals and Objectives
PCSS’ Mission is to promote evidence-based resources and clinical practices.

1.)    Maintain and expand a comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder.

Training is designed to increase the knowledge base and clinical proficiency of prescribers and providers from diverse multi-disciplinary healthcare backgrounds. An on-line curriculum includes:

  • Patient selection and matching with treatment setting (residential, outpatient program, office-based) and specific medications (methadone, buprenorphine, or naltrexone)
  • Practical guidelines for detoxification (both outpatient and inpatient)
  • Implementing antagonist-based treatment, managing long-term maintenance on medications
  • Transitioning from agonist- to antagonist-based treatment
  • Managing substance use and co-occurring psychiatric disorders
  • Treatment of individuals with co-occurring medical problems and chronic pain
  • Treatment in specialized populations such as adolescents, elderly, pregnant women, and those involved in veterans and criminal justice healthcare systems (for detailed description of the training curriculum, see below).

The content of educational resources is overseen by a panel of experienced clinicians, researchers, and educators forming a Clinical Expert Panel.

2.)    Expand existing clinical mentoring program to provide guidance to prescribers and key health professionals on prevention, identification, and treatment of opioid use disorder.

  • The program provides clinical mentors and matches them with clinicians. Communications between mentors and clinicians is primarily via phone and Internet (email, video). A discussion forum, moderated by an addiction expert, allows healthcare professionals to post questions and to encourage communication among a wide range of providers.
3.)    Expand MOUD training for physicians, nurse practitioners, and physician assistants.
  • All PCSS trainings are FREE and available to physicians, physicians’ assistants, nurse practitioners and other medical professionals.·         

For More Information and FREE training and educational resources on MOUD visit

Funding for this initiative was made possible (in part) by cooperative agreement nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.”


Non-members interested in CME must create a profile with AOAAM. Subscribe now or Join Us to receive the full benefits of membership.

Latest News  read more

The 8-hour MOUD Training

Hot Topics in

Addiction Medicine

On-demand CME

- Live CME

The mission of the American Osteopathic Academy of Addiction Medicine is to improve the health of individuals and families burdened with the disease of addiction.

Powered by Wild Apricot Membership Software